Benzaldehyde → HCID 22674379, compound
Reaction equation
Cl[C:2]1[C:3]2[S:14][CH:13]=[CH:12][C:4]=2[N:5]=[C:6]([C:8]([F:11])([F:10])[F:9])[N:7]=1.[CH:15](=[O:22])[C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1.[I-].C[N+]1(C)C=CN=C1.[H-].[Na+]>C1COCC1.O>[C:16]1([C:15]([C:2]2[C:3]3[S:14][CH:13]=[CH:12][C:4]=3[N:5]=[C:6]([C:8]([F:11])([F:10])[F:9])[N:7]=2)=[O:22])[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
A suspension of 4-chloro-2-trifluoromethylthieno[3,2-d]pyrimidine (0.3 g, 1.26 mmol), benzaldehyde (0.28 g, 2.64 mmol) and N,N-dimethylimidazolium iodide (0.2 g, 0.89 mmol) in THF (8 mL) was treated with NaH (60% dispersion in oil, 0.112 g, 2.8 mmol), refluxed for 15 min, cooled to room temperature, treated with water (4 mL) and the organic phase separated. The aqueous phase was extracted with CH2Cl2 (2×20 mL), the combined organic phase washed with brine (10 mL), dried (MgSO4), concentrated in vacuo and the resulting brown oil purified by chromatography [SiO2; heptane-EtOAc (3:1)] then recrystallised from heptane to give the title compound (280 mg, 43%) as yellow needles.
Workup
- temperaturerefluxed for 15 min
- customthe organic phase separated
- extractionThe aqueous phase was extracted with CH2Cl2 (2×20 mL)
- washthe combined organic phase washed with brine (10 mL)
- dry with materialdried (MgSO4)
- concentrationconcentrated in vacuo
- customthe resulting brown oil purified by chromatography [SiO2; heptane-EtOAc (3:1)]
- customthen recrystallised from heptane
Sources & evidence
- ORD record
- ord-2c70b2d3400a463ebfde38c88cd8187e
- Source dataset
- uspto-grants-2004_09
- Patent number
- US06787541B1
Reaction notes
Loading…